VAGELOS P ROY

Insider Reports History

Signature
/s/**P. Roy Vagelos
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by VAGELOS P ROY:

Company Role Class Num Shares Value Price $ Report Date Ownership
REGENERON PHARMACEUTICALS, INC. Director Common Stock 312,578 $297,342,948 $951.26 03 Apr 2023 Direct
REGENERON PHARMACEUTICALS, INC. Director Common Stock 125,493 $119,376,471 $951.26 03 Apr 2023 by CLAT
REGENERON PHARMACEUTICALS, INC. Director Common Stock 23,461 $22,317,511 $951.26 03 Apr 2023 by Spouse as Trustee
REGENERON PHARMACEUTICALS, INC. Director Common Stock 3,609 $3,433,097 $951.26 03 Apr 2023 by trust for grandch
REGENERON PHARMACEUTICALS, INC. Director Common Stock 1,963 $1,867,323 $951.26 03 Apr 2023 By 401(k) Plan
REGENERON PHARMACEUTICALS, INC. Director Non-Qualified Stock Option (right to buy) 85,000 22 Feb 2023 Direct

Insider Reports Filed by VAGELOS P ROY

Symbol Company Period Transactions Value $ Form Type Role Filing Time
REGN REGENERON PHARMACEUTICALS, INC. 03 Apr 2023 1 $0 4 Director 05 Apr 2023, 16:02
REGN REGENERON PHARMACEUTICALS, INC. 23 Mar 2023 1 $0 4 Director 27 Mar 2023, 16:42
REGN REGENERON PHARMACEUTICALS, INC. 22 Feb 2023 4 -$10,265,116 4 Director 24 Feb 2023, 15:07
REGN REGENERON PHARMACEUTICALS, INC. 20 Dec 2022 2 -$102,864 4 Director 21 Dec 2022, 16:45
REGN REGENERON PHARMACEUTICALS, INC. 16 Dec 2022 2 $0 4 Director 20 Dec 2022, 16:44
REGN REGENERON PHARMACEUTICALS, INC. 09 Dec 2022 5 -$42,937 4 Director 13 Dec 2022, 15:12
REGN REGENERON PHARMACEUTICALS, INC. 30 Mar 2022 2 -$20,000,686 4 Director 01 Apr 2022, 16:08
REGN REGENERON PHARMACEUTICALS, INC. 14 Mar 2022 4 -$18,086,665 4 Director 15 Mar 2022, 16:01
REGN REGENERON PHARMACEUTICALS, INC. 16 Dec 2021 2 -$80,008 4 Director 20 Dec 2021, 15:13
REGN REGENERON PHARMACEUTICALS, INC. 08 Dec 2021 3 $0 4 Director 10 Dec 2021, 16:35
REGN REGENERON PHARMACEUTICALS, INC. 25 Aug 2021 3 -$19,455,564 4 Director 27 Aug 2021, 16:01
REGN REGENERON PHARMACEUTICALS, INC. 18 Aug 2021 6 -$6,525,752 4 Director 19 Aug 2021, 16:05